| mRNA |
selumetinib:tretinoin (2:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0032 |
0.9 |
| mRNA |
BX-912 |
GDSC1000 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
CI-976 |
CTRPv2 |
pan-cancer |
AAC |
0.0034 |
0.9 |
| mRNA |
selumetinib:BRD-A02303741 (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.003 |
0.9 |
| mRNA |
BRD-K79669418 |
CTRPv2 |
pan-cancer |
AAC |
-0.0044 |
0.9 |
| mRNA |
Gemcitabine |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |
| mRNA |
avicin D |
CTRPv2 |
pan-cancer |
AAC |
-0.0041 |
0.9 |
| mRNA |
BRD-K27986637 |
CTRPv2 |
pan-cancer |
AAC |
-0.0056 |
0.9 |
| mRNA |
SN-38 |
CTRPv2 |
pan-cancer |
AAC |
0.0027 |
0.9 |
| mRNA |
navitoclax:pluripotin (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.0026 |
0.9 |